Page 8 - Alimera Sciences News Today

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note released on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on ALIM. HC Wainwright decreased their price objective on Alimera Sciences from $9.00 to […]

Ocular Surgery News | The recent approval of pegcetacoplan for geographic atrophy, which may be followed shortly by avacincaptad pegol, is the first milestone answer to an unmet need, giving hope to patients who so far had no treatment options.It also paves the way for revolutionary changes in clinical practice, research, investment decisions and health care planning.

Investment analysts at StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report issued on Wednesday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Several other analysts also recently issued reports on ALIM. Craig Hallum decreased their price objective on shares of Alimera Sciences from $18.00 […]

FinancialContent fully hosted finance channel

Analysts’ new coverage for Wednesday, May 24th: StockNews.com initiated coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. Sanford C. Bernstein assumed coverage on shares of Ambev (NYSE:ABEV). They […]

Analysts’ new coverage for Wednesday, May 24th: StockNews.com initiated coverage on shares of ATA Creativity Global (NASDAQ:AACG). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. Sanford C. Bernstein assumed coverage on shares of Ambev (NYSE:ABEV). They […]

Alimera Sciences (NASDAQ:ALIM – Get Rating) had its target price trimmed by HC Wainwright from $9.00 to $5.00 in a research report released on Friday, The Fly reports. HC Wainwright also issued estimates for Alimera Sciences’ Q2 2023 earnings at ($0.22) EPS, Q3 2023 earnings at ($0.19) EPS, Q4 2023 earnings at ($0.10) EPS, FY2023 […]

Alimera Sciences, Inc. (NASDAQ:ALIM – Get Rating) – Stock analysts at HC Wainwright increased their Q2 2023 earnings estimates for Alimera Sciences in a research note issued to investors on Tuesday, May 16th. HC Wainwright analyst Y. Chen now forecasts that the biopharmaceutical company will post earnings of ($0.22) per share for the quarter, up […]

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report report published on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on ALIM. HC Wainwright reissued a buy rating and set a $9.00 price target […]

Gainers Monogram Orthopaedics Inc. (NASDAQ:MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Or...